Meyka Pro banner
Lannett Company, Inc.

Lannett Company, Inc. (LCI) Stock Overview

Explore Lannett Company, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LCINYSE
HealthcareDrug Manufacturers - Specialty & Generic
$0.69
$0.03(3.86%)
U.S. Market is Open · 13:55

Lannett Company, Inc. (LCI)

Meyka AI Score

Z

Key Financials

Market Cap7.4M
P/E Ratio-0.03
EPS (TTM)$-19.14
ROE1.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

LCI Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Lannett Company, Inc. (NYSE: LCI) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Lannett Company, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LCI on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NYSE listing.

Key metrics behind Lannett Company, Inc.'s NYSE-traded stock include a P/E ratio of -0.03 and a market capitalization of 7.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LCI on the NYSE.

Price Performance (NYSE: LCI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-72.36%
6-Month Change
-71.20%
Year-to-Date (YTD) Change
-67.79%
1-Year Change
-67.48%
3-Year Change
-97.62%
5-Year Change
-98.99%
All-Time (Max) Change
-93.57%

Contact Information

215 333 9000
1150 Northbrook Drive, Trevose, PA, 19053

Company Facts

5,640 Employees
IPO DateDec 13, 2013
CountryUS

Frequently Asked Questions